Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results
Get Alerts BSX Hot Sheet
Join SI Premium – FREE
Additionally, the company will webcast its conference call discussing financial results and business highlights for the second quarter ended
A live webcast and replay for each event will be accessible at https://investors.bostonscientific.com. The replays will be available approximately one hour following the completion of each event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and follow us on LinkedIn.
CONTACTS:
Media Relations
+1 (508) 382-0288
[email protected]
Investor Relations
+1 (508) 683-4479
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-participation-in-bernsteins-42nd-annual-strategic-decisions-conference-and-conference-call-discussing-second-quarter-2026-results-302760793.html
SOURCE Boston Scientific Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- BofA lists top 5 themes driving next $1tn in incremental semi sales
- dōTERRA Spotlights Summer Wellness Essentials for Every Adventure
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Sanford C. Bernstein, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share